Y-Intercept (HK)’s Supernus Pharmaceuticals SUPN Stock Holding History

Y-Intercept (HK)’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.97M	Buy	45,724 +7,230	+19%	+$330K	0.04%	639
2026 Q2	$1.79M	Buy	38,494 +18,258	+90%	+$877K	0.04%	763
2026 Q1	$1.05M	Buy	20,236 +3,096	+18%	+$158K	0.02%	1014
2025 Q4	$852K	Buy	+17,140	New	+$833K	0.02%	1050
2023 Q4	–	Sell	-16,131	Closed	-$445K	–	1626
2023 Q3	$445K	Buy	+16,131	New	+$491K	0.04%	608

Other funds holding SUPN

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Campbell Newman Asset Management Milwaukee, Wisconsin $1.33B AUM 26.63% 1-Year Est. Return

MAM

Mystic Asset Management Warwick, Rhode Island $451M AUM 22.13% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

James Investment Research Alpha, Ohio $936M AUM 24.49% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Y-Intercept (HK)'s SUPN Position: Q3 2026 in Review

Y-Intercept (HK) increased its Supernus Pharmaceuticals (SUPN) stake by 19% in Q3 2026, buying an estimated $330K and bringing the position to 45,724 shares worth $1.97M. The position accounts for 0.04% of the portfolio, ranked #639.

Y-Intercept (HK) first reported a position in SUPN in Q3 2023 and has held it in 5 quarters since. 51 funds tracked by Wall St. Rank hold SUPN as of Q3 2026.

Y-Intercept (HK) held 45,724 shares of Supernus Pharmaceuticals worth $1.97M as of Q3 2026.
Y-Intercept (HK) bought 7,230 Supernus Pharmaceuticals shares in Q3 2026, an estimated $330K.
Supernus Pharmaceuticals made up 0.04% of Y-Intercept (HK)'s portfolio in Q3 2026, its #639 holding.
Y-Intercept (HK) first reported a position in Supernus Pharmaceuticals in Q3 2023 and has held it in 5 quarters since.
51 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.